Cargando…
Effects of anti‐IL5 biological treatments on blood IgE levels in severe asthmatic patients: A real‐life multicentre study (BIONIGE)
BACKGROUND: Mepolizumab and benralizumab are clinically effective biological treatments for severe eosinophilic asthmatic patients by hampering eosinophilic inflammation. The effects of these compound on the immunoglobulin (Ig)E T2 component are virtually unknown. OBJECTIVES: To evaluate the change...
Autores principales: | Contoli, Marco, Santus, Pierachille, Menzella, Francesco, Rocchi, Cindy, Radovanovic, Dejan, Baraldi, Federico, Martelli, Chiara, Casanova, Serena, Barbetta, Carlo, Micheletto, Claudio, Scichilone, Nicola, Beghè, Bianca, Carpagnano, Elisiana, Papi, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988861/ https://www.ncbi.nlm.nih.gov/pubmed/35423001 http://dx.doi.org/10.1002/clt2.12143 |
Ejemplares similares
-
A Framework For Step Down Or Therapeutic Re-Organization For Withdrawal Of Inhaled Corticosteroids In Selected Patients With COPD: A Proposal For COPD Management
por: Micheletto, Claudio, et al.
Publicado: (2019) -
High Level of Blood Eosinophils and Localization of Bronchiectasis in Patients with Severe Asthma: A Pilot Study
por: Quaranta, Vitaliano Nicola, et al.
Publicado: (2023) -
Can Leukotriene Receptor Antagonist Therapy Improve the Control of Patients with Severe Asthma on Biological Therapy and Coexisting Bronchiectasis? A Pilot Study
por: Quaranta, Vitaliano Nicola, et al.
Publicado: (2022) -
Sublobar resection: functional evaluation and pathophysiological considerations
por: Santus, Pierachille, et al.
Publicado: (2020) -
Mucins and Asthma: Are We Headed to the Revolutionary Road?
por: Santus, Pierachille, et al.
Publicado: (2019)